TY  - JOUR

T1  - Temozolomide: a novel oral alkylating agent.

JO  - Expert Rev Anticancer Ther

PY  - 2001/06/01

AU  - Danson SJ

AU  - Middleton MR

ED  - 

DO  - DOI: 10.1586/14737140.1.1.13

VL  - 1

IS  - 1

SP  - 13

EP  - 19

Y2  - 2024/09/19

ER  -